¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Leukemia Inhibitory Factor Receptor alpha Subunit"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
14
¿µ¹®
ÇѱÛ
intrinsic factor
³»ÀÎÀÎÀÚ, ³»ÀÎÀÚ
initiation factor
½ÃÀÛÀÎÀÚ
insulin-like growth factor
Àν¶¸°À¯»ç¼ºÀåÀÎÀÚ
ketogenic factor
ÄÉÅæ»ý¼ºÀÎÀÚ
labile factor
1. ºÒ¾ÈÁ¤ÀÎÀÚ 2. ºÒ¾ÈÁ¤¿ä¼Ò
leukotaxic factor
¹éÇ÷±¸½ò¸²ÀÎÀÚ
luteinizing hormone releasing factor
Ȳ(»ö)üÇü¼ºÈ£¸£¸óºÐºñÀÎÀÚ
lymphocyte activating factor
¸²ÇÁ±¸È°¼ºÀÎÀÚ
lactogenic factor
Á¥ÃËÁøÀÎÀÚ
lymphocytosis stimulating factor
¸²ÇÁ±¸Áõ°¡ÀÚ±ØÀÎÀÚ
migration inhibition factor
À̵¿ÀúÁöÀÎÀÚ
mitogenic factor
ºÐ¿ÃËÁøÀÎÀÚ
myocardial depressant factor
½É(Àå)±Ù(À°)¾ïÁ¦ÀÎÀÚ
macrophage aggregating factor
Å«Æ÷½Ä¼¼Æ÷ÀÀÁýÀÎÀÚ, ´ë½Ä¼¼Æ÷ÀÀÁýÀÎÀÚ
macrophage arming factor
Å«Æ÷½Ä¼¼Æ÷¹«ÀåÀÎÀÚ, ´ë½Ä¼¼Æ÷¹«ÀåÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
14
¿µ¹®
ÇѱÛ
plasma thromboplastin factor
Ç÷À寮·Òº¸ÇÃ¶ó½ºÆ¾ÀÎÀÚ
platelet activating factor
Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ
platelet-derived growth factor
Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
precipitation factor
ÃËÁø¿äÀÎ
predisposing factor
¼±Çà¿äÀÎ
prognostic factor
¿¹ÈÄÀÎÀÚ
prolactin releasing factor
ÇÁ·Î¶ôƾºÐºñÀ¯¹ßÀÎÀÚ
protein synthesis factor
´Ü¹éÇÕ¼ºÀÎÀÚ
psychogenic factor
Á¤½Å¼º¿ä¼Ò
psychological factor
½É¸®¿ä¼Ò
psychosocial factor
½É¸®»çȸÀû¿äÀÎ
quality factor
Áú¿ä¼Ò, Á¤¼ºÀÎÀÚ
racial factor
ÀÎÁ¾¿äÀÎ
radiation weighting factor
¹æ»ç¼±°¡Áß°è¼ö
realization factor
½ÇÇöÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
14
¿µ¹®
ÇѱÛ
Fibroblast growth factor
¼¶À¯¸ð¼¼Æ÷(àéë«Ù½á¬øà)¼ºÀå¿äÀÎ(à÷íþé©ì×)
G-CSF (Granulocyte colony-stimulating factor)
°ú¸³¼¼Æ÷±ºÃËÁøÀÎÀÚ(Î¨Ø£á¬øàÏØõµòäì×í)
GH releasing factor
¼ºÀå(à÷íþ)È£¸£¸ó À¯¸®ÀÎÀÚ(ë´×îì×í).
GH releasing factor
¼ºÀåÈ£¸£¸óÀ¯¸®ÀÎÀÚ.
Growth factor
¼ºÀåÀÎÀÚ(à÷íþì×í)
Hageman factor
ÇϰԸ¸ÀÎÀÚ
Hydrostatic factor
Á¤¼öÀÎÀÚ(ð¡â©ì×í)
IGF-I(insulin-like growth factor-I)
Àν¶¸° À¯»ç ¼ºÀåÀÎÀÚ-1
Luteinization -inhibiting factor
ȲüȾïÁ¦¿äÀÎ(üÜô÷ûùåäð¤é©ì×)
Macrophage colony-stimulating factor
´ë½Ä¼¼Æ÷Áý¶ôÇü¼ºÃËÁøÀÎÀÚ(ÓÞãÝá¬øàó¢Õªû¡à÷õµòäì×í)à÷õµòäì×?
NGF=>nerve growth factor
½Å°æ¼ºÀåÀÎÀÚ
PAF =platelet activating factor
Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ.
PAF= platelet activating factor
Ç÷¼ÒÆÇ Ȱ¼ºÀÎÀÚ.
Q factor
Å¥ ÀÎÀÚ
Q-factor
Å¥-ÀÎÀÚ (ì×í)
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
14
¿µ¹®
ÇѱÛ
receptor gradient
¼ö¿ëü°æ»ç.
receptor hypothesis
¼ö¿ëü°¡¼³
receptor imaging
¼ö¿ëü¿µ»ó(È)
receptor organ
¼ö¿ë±â°ü(áôé»Ðïί).
receptor potential
¼ö¿ë±âÀüÀ§.
receptor sensitivity
¼ö¿ëü °¨¼ö¼º
receptor site
¼ö¿ëüºÎÀ§.
receptor stimulants
¼ö¿ëüÀÚ±ØÁ¦.
receptor supersensitivity
¼ö¿ëü Ãʰ¨¼ö¼º(áôéÄô÷ õ±Êïáôàõ)
receptor, T cell
T¼¼Æ÷(Ç׿ø)¼ö¿ëü
receptor-ligand interaction
¼ö¿ëü-¹èÀ§ÀÚ »óÈ£ÀÛ¿ë
retinoic acid receptor
·¹Æ¼³ëÀλê¼ö¿ëü
secondary receptor
ÀÌÂ÷¼º ¼ö¿ë±â(¡áôé»Ðï).
sensory receptor
°¨°¢¼ö¿ëü.
sigma receptor
½Ã±×¸¶¼ö¿ëü
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
14
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
14
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
14
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
14
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
14
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
14
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½